Naltrexone/bupropion (Mysimba▼): risk of adverse reactions that could affect ability to drive

Source:
GOV UK
Publisher:
Medicines and Healthcare products Regulatory Agency
Publication date:
19 August 2019

Abstract

Advise patients that naltrexone/bupropion has been associated with adverse reactions such as dizziness or somnolence, which can affect ability to drive, operate machinery, or perform dangerous tasks.